FILA ANTI-DOPING REGULATIONS

FILA ANTI-DOPING REGULATIONS - 1 -

TABLE OF CONTENTS ARTICLE 1 DEFINITION OF DOPING... 5 ARTICLE 2 ANTI-DOPING RULE VIOLATIONS... 5 ARTICLE 3 PROOF OF DOPING... 7 ARTICLE 4 THE PROHIBITED LIST... 8 ARTICLE 5 TESTING...12 ARTICLE 6 ANALYSIS OF SAMPLES...15 ARTICLE 7 RESULTS MANAGEMENT...16 ARTICLE 8 RIGHT TO A FAIR HEARING...18 ARTICLE 9 AUTOMATIC DISQUALIFICATION OF INDIVIDUAL RESULTS...21 ARTICLE 10 ARTICLE 11 ARTICLE 12 ARTICLE 13 ARTICLE 14 SANCTIONS ON INDIVIDUALS...21 CONSEQUENCES TO TEAMS...30 SANCTIONS AGAINST NATIONAL FEDERATIONS AND THEIR OFFICIALS...30 APPEALS...32 NATIONAL FEDERATIONS INCORPORATION OF FILA REGULATIONS, REPORTING AND RECOGNITION...35 ARTICLE 15 RECOGNITION OF DECISIONS BY OTHER ORGANISATIONS...37 ARTICLE 16 ARTICLE 17 ARTICLE 18 STATUTE OF LIMITATIONS...38 FILA COMPLIANCE REPORT TO WADA...38 AMENDMENT AND INTERPRETATION OF ANTI-DOPING REGULATIONS...38-2 -

INTRODUCTION Preface At the FILA Congress held on September 19 th, 2002 in Moscow, the FILA Congress approved the draft of the World Anti-Doping Code in its general outline and gave full authority to the FILA Executive Committee to approve the final version of the Code proposed by WADA. These Anti-Doping Regulations are adopted and implemented in conformance with FILA's responsibilities under the Code, and are in furtherance of FILA's continuing efforts to eradicate doping in the sport of wrestling. Anti-Doping Rules, like Competition rules, are sport rules governing the conditions under which wrestling is practiced. Wrestlers accept these rules as a condition of participation. Anti-Doping Rules are not intended to be subject to or limited by the requirements and legal standards applicable to criminal proceedings or employment matters. The policies and minimum standards set forth in the Code and implemented in these Anti-Doping Regulations represent the consensus of a broad spectrum of stakeholders with an interest in fair sport and should be respected by all courts and adjudicating bodies. Fundamental Rationale for the Code and FILA's Anti-Doping Regulations Anti-doping programs seek to preserve what is intrinsically valuable about sport. This intrinsic value is often referred to as "the spirit of sport"; it is the essence of Olympism; it is how we play true. The spirit of sport is the celebration of the human spirit, body and mind, and is characterized by the following values: Ethics, fair play and honesty Health Excellence in performance Character and education Fun and joy Teamwork Dedication and commitment Respect for rules and laws Respect for self and other participants Courage Community and solidarity Doping is fundamentally contrary to the spirit of the sport. FILA Anti-Doping Regulations Update January 2009 3

Scope These Anti-Doping Regulations shall apply to FILA, each affiliated National Federation of FILA, and each Participant in the activities of FILA or any of its National Federations by virtue of the Participant's membership, accreditation, or participation in FILA, its National Federations, or their activities or Events. Any Person, member of a National Federation and who fulfils the requirements to be part of the FILA Registered Testing Pool must make himself or herself available for Testing, at least six months before participating in International Events or events of his/her National Federation. To be eligible for participation in FILA events, a competitor must have an FILA license issued through his or her National Federation. The FILA licence will only be issued to competitors who have personally signed the Appendix 1, in the actual form approved by the FILA Executive Committee. All forms from under-age applicants must be counter-signed by their legal guardians. The National Federation must guarantee that all wrestlers registered for a FILA License accept the Rules of the FILA, including these FILA Anti-Doping Regulations compiled in accordance with the World Anti-Doping Code It is the responsibility of each National Federation to ensure that all national-level Testing on the National Federation's Wrestlers complies with these Anti-Doping Regulations. In some cases, the National Federation itself will be conducting the Doping Control described in these Anti-Doping Regulations. In other countries, many of the Doping Control responsibilities of the National Federation have been delegated or assigned by statute to a National Anti-Doping Organization. In those countries, references in these Anti-Doping Rules to the National Federation shall apply, as applicable, to the National Federation's National Anti-Doping Organization. These Anti-Doping Regulations shall apply to all Doping Controls over which FILA and its National Federations have jurisdiction. FILA Anti-Doping Regulations Update January 2009 4

ARTICLE 1 DEFINITION OF DOPING Doping is defined as the occurrence of one or more of the anti-doping rule violations set forth in Article 2.1 through Article 2.8 of the World Anti-Doping Code and these Anti-Doping Regulations. ARTICLE 2 ANTI-DOPING RULE VIOLATIONS The following constitute anti-doping rule violations: 2.1 The presence of a prohibited substance or its metabolites or markers in a sample provided by the Wrestler 1 2.1.1 It is each wrestler s personal duty to ensure that no Prohibited Substance enters his or her body. Wrestlers are responsible for any Prohibited Substance or its Metabolites or Markers found to be present in their Samples. Accordingly, it is not necessary that intent, fault, negligence or knowing use on the wrestler s part be demonstrated in order to establish an anti-doping violation under Article 2.1. 2.1.2 Sufficient proof of an anti-doping rule violation under Article 2.1 is established by either of the following: presence of a Prohibited Substance or its Metabolites or Markers in the Wrestler s A Sample where the wrestler waives analysis of the B Sample and the B Sample is not analyzed; or, where the Wrestler s B Sample is analyzed and the analysis of the Wrestler s B Sample confirms the presence of the Prohibited Substance or its Metabolites or Markers found in the Wrestler s A Sample. 2.1.3 Excepting those substances for which a quantitative reporting threshold is specifically identified in the Prohibited List, the detected presence of any quantity of a Prohibited Substance or its Metabolites or Markers in a Wrestler s Sample shall constitute an anti-doping rule violation. 2.1.4 As an exception to the general rule of Article 2.1, the Prohibited List or International Standards may establish special criteria for the evaluation of Prohibited Substances that can also be produced endogenously. 2.2 Use or Attempted Use of a Prohibited Substance or a Prohibited Method by a wrestler 2.2.1 It is each Wrestler s personal duty to ensure that no Prohibited Substance enters his or her body. Accordingly, it is not 1 The word Wrestler is used for both man and woman athletes in all the articles of the present regulations. FILA Anti-Doping Regulations Update January 2009 5

necessary that intent, fault, negligence or knowing Use on the wrestler s part be demonstrated in order to establish an antidoping violation for Use of a Prohibited Substance or a Prohibited Method. 2.2.2 The success or failure of the Use of a Prohibited Substance or Prohibited Method is not material. It is sufficient that the Prohibited Substance or Prohibited Method was used or attempted to be used for an anti-doping rule violation to be committed. 2.3 Refusing or failing without compelling justification to submit to sample collection after notification as authorized in applicable anti-doping rules, or otherwise evading sample collection. 2.4 Violation of applicable requirements regarding wrestler availability for Out-of-Competition testing including failure to provide required whereabouts information and missed tests which are declared based on rules which comply with the International Standard for Testing. Any combination of three missed tests and/or filing failures within an eighteen-month period as determined by Anti-Doping Organizations with jurisdiction over the Wrestler shall constitute an anti-doping rule violation. 2.5 Tampering, or attempted tampering with any part of the Doping Control. 2.6 Possession of Prohibited Substances and Methods 2.6.1 Possession by a Wrestler In-Competition of any Prohibited Method or any Prohibited Substance, or Possession by an Wrestler Out-of-Competition of any Prohibited Method or any Prohibited Substance which is prohibited in Out-of-Competition Testing, unless the Wrestler establishes that the Possession is pursuant to a therapeutic use exemption granted in accordance with Article 4.4 (Therapeutic Use) or other acceptable justification. 2.6.2 Possession by a Wrester Support Personnel In-Competition of any Prohibited Method or any Prohibited Substance, or Possession by a Wrestler Support Personnel Out-of-Competition of any Prohibited Method or any Prohibited Substance which is permanently prohibited, in connection with a Wrestler, Competition or training, unless the Wrestler Support Personnel establishes that the possession is pursuant to a therapeutic use exemption granted to a Wrestler in accordance with Article 4.4 (Therapeutic Use) or other acceptable justification. FILA Anti-Doping Regulations Update January 2009 6

2.7 Trafficking or attempted trafficking in any Prohibited Substance or Prohibited Method 2.8 Administration or attempted administration to any Wrestler In- Competition of any Prohibited Method or Prohibited Substance, or administration or attempted administration to any Wreslter Out-of- Competition of any Prohibited Method or any Prohibited Substance that is prohibited in Out-of-Competition Testing, or assisting, encouraging, aiding, abetting, covering up or any other type of complicity involving an anti-doping rule violation or any Attempted anti-doping rule violation. ARTICLE 3 PROOF OF DOPING 3.1 Burdens and Standards of Proof FILA and its National Federations shall have the burden of establishing that an anti-doping rule violation has occurred. The standard of proof shall be whether the FILA or its National Federations has established an anti-doping rule violation to the comfortable satisfaction of the hearing panel which will assess the seriousness of the allegation which is made. This standard of proof in all cases must be greater than a mere balance of probability but less than proof beyond a reasonable doubt. Where these Regulations place the burden of proof upon the Athlete or other Person alleged to have committed an anti-doping rule violation to rebut a presumption or establish specified facts or circumstances, the standard of proof shall be by a balance of probability, except as provided in Articles 10.4 and 10.6 where the Wrestler must satisfy a higher burden of proof. 3.2 Methods of Establishing Facts and Presumptions Facts related to anti-doping rule violations may be established by any reliable means, including admissions. The following rules of proof shall be applicable in doping cases: 3.2.1 WADA-accredited laboratories are presumed to have conducted sample analysis and custodial procedures in accordance with the International Standard for laboratory. The Wrestler or other person may rebut this presumption by establishing that a departure from the International Standard occurred which could reasonably have caused the adverse analytical finding. If the Wrestler or other person rebuts the preceding presumption by showing that a departure from the International Standard occurred which could reasonably have caused the adverse analytical finding, then the FILA and its National Federations shall have the burden to establish that such departure did not cause the Adverse Analytical Finding. FILA Anti-Doping Regulations Update January 2009 7

3.2.2 Departures from any other International Standard or other antidoping rule or policy which did not cause an Adverse Analytical Finding or other anti-doping rule violation shall not invalidate such results. If the Wrestler or other Person establishes that a departure from another International Standard or other antidoping rule or policy which could reasonably have caused the Adverse Analytical Finding occurred, then the Anti-Doping Organization shall have the burden to establish that such departure did not cause the Adverse Analytical Finding or the factual basis for the anti-doping rule violation. 3.2.3 The facts established by a decision of a court or professional disciplinary tribunal of competent jurisdiction which is not the subject of a pending appeal shall be irrefutable evidence against the Wrestler or other person to whom the decision pertained of those facts unless the Wrestler or other person establishes that the decision violated principles of natural justice. 3.2.4 The tribunal in a hearing on an anti-doping rule violation may draw an inference adverse to the Wrestler or other person who is asserted to have committed an anti-doping rule violation based on the Wrestler or other person s refusal, after a request made in a reasonable time in advance of the hearing, to appear at the hearing (either in person or telephonically as directed by the tribunal) and to answer questions either from the tribunal or from FILA or its National Federation asserting the anti-doping rule violation. ARTICLE 4 THE PROHIBITED LIST 4.1 Publication and Revision of the Prohibited List WADA shall, as often as necessary and no less often than annually, publish the Prohibited List as an International Standard which Prohibited List is hereby incorporated into these regulations. The proposed content of the Prohibited List and all revisions shall be provided in writing promptly to all Signatories and governments for comment and consultation. Each annual version of the Prohibited List and all revisions shall be distributed promptly by WADA to each Signatory and government and shall be published on WADA's website, and each Signatory shall take appropriate steps to distribute the Prohibited List to its and constituents. FILA will make available the Prohibited List to each National Federation and each National Federation will ensure that the Prohibited List in force is available for its members and constituents 2. 2 The Prohibited List in force is available on WADA's website at www.wada-ama.org and on FILA s site at www.fila-wrestling.com FILA Anti-Doping Regulations Update January 2009 8

4.2 Prohibited Substances and Prohibited Methods Identified on the Prohibited List Unless provided otherwise in the Prohibited List and/or a revision, the Prohibited List and revisions shall go into effect under these Anti-Doping Regulations three months after publication of the Prohibited List by WADA without requiring any further action by FILA. As described in Article 4.2 of the Code, FILA may request that WADA expand the Prohibited List for the sport of wrestling. FILA may also [upon the recommendation of its Anti-Doping Commission] request that WADA include additional substances or methods, which have the potential for abuse in the sport of wrestling, in the monitoring program described in Article 4.5 of the Code. As provided in the Code, WADA shall make the final decision on such requests by FILA. 4.2.1 Prohibited Substances and Prohibited Methods The Prohibited List shall identify those Prohibited Substances and Prohibited Methods which are prohibited as doping at all times (both In-Competition and Out-of-Competition) because of their potential to enhance performance in future Competitions or their masking potential and those substances and methods which are prohibited In-Competition only. The Prohibited List may be expanded by WADA. Prohibited Substances and Prohibited Methods may be included in the Prohibited List by general category (e.g., anabolic agents) or by specific reference to a particular substance or method. 4.2.2 Specified Substances All Prohibited Substances, except substances in the classes of anabolic agents and hormones and those stimulants so identified on the Prohibited List, shall be Specified Substances for purposes of the application of Article 10 (Sanctions on Individuals). Prohibited Methods shall not be Specified Substances. 4.2.3 New Classes of Prohibited Substances In the event WADA expands the Prohibited List by adding a new class of Prohibited Substances in accordance with Article 4.1, WADA s Executive Committee shall determine whether any or all Prohibited Substances within the new class of Prohibited Substances shall be considered Specified Substances under Article 4.2.2. FILA Anti-Doping Regulations Update January 2009 9

4.3 Criteria for Including Substances and Methods on the Prohibited List WADA shall consider the following criteria in deciding whether to include a substance or method on the Prohibited List. 4.3.1 A substance or method shall be considered for inclusion on the Prohibited List if WADA determines that the substance or method meets any two of the following three criteria: 4.3.1.1 Medical or other scientific evidence, pharmacological effect or experience that the substance or method, alone or in combination with other substances or methods, has the potential to enhance or enhances sport performance. 4.3.1.2 Medical or other scientific evidence, pharmacological effect, or experience that the use of the substance or method represents an actual or potential health risk to the Wrestler; 4.3.1.3 WADA's determination that the Use of the substance or method violates the spirit of sport described in the Introduction to the Code. 4.3.2 A substance or method shall also be included on the Prohibited List if WADA determines there is medical or other scientific evidence, pharmacological effect or experience that the substance or method has the potential to mask the use of other Prohibited Substances and Prohibited Methods. 4.3.3 WADA s determination of the Prohibited Substances and Prohibited Methods that will be included on the Prohibited List and the classification of substances into categories on the Prohibited List is final and shall not be subject to challenge by a Wrestler or other Person based on an argument that the substance or method was not a masking agent or did not have the potential to enhance performance, represent a health risk, or violate the spirit of sport. 4.4 Therapeutic Use 4.4.1 International level Wrestlers (holding the FILA licence) with a documented medical condition requiring the use of a Prohibited Substance or a Prohibited Method must first obtain a Therapeutic Use Exemption ("TUE"). The presence of a Prohibited Substance or its Metabolites or Markers (Article 2.1), Use or Attempted Use of a Prohibited Substance or a Prohibited Method (Article 2.2), Possession of Prohibited Substances and Methods (Article 2.6) or Administration of a Prohibited Substance or Prohibited Method (Article 2.8) FILA Anti-Doping Regulations Update January 2009 10

consistent with the provisions of an applicable therapeutic use exemption and issued pursuant to the International Standard for Therapeutic Use Exemptions shall not be considered an anti-doping rule violation. 4.4.2 Wrestlers included by FILA in its Registered Testing Pool and other Wrestlers prior to their participation in any International Event must obtain a TUE from FILA (regardless of whether the wrestler previously has received a TUE at the national level). TUE's granted by FILA shall be reported to the wrestler's National Federation and to WADA. Other wrestlers subject to testing must obtain a TUE from their National Anti-Doping Organization or other authorized body designated by their National Federation. National Federations shall promptly report any such TUE s to FILA and WADA. 4.4.3 The FILA Executive Committee shall appoint a panel of physicians to consider requests for TUE's (the "TUE Commission). Upon FILA's receipt of a TUE request, the Chair of the TUE Commission shall appoint one or more members of the TUE Commission (which may include the Chair) to consider such request. The TUE Panel member(s) so designated shall promptly evaluate such request in accordance with the International Standard for Therapeutic Use Exemptions and render a decision on such request, which shall be the final decision of FILA. 4.4.3.1 International-level Wrestlers who are included in the FILA's Registered Testing Pool should apply to FILA for the TUE at the same time they first provide whereabouts information to the FILA and, except in emergency situations, no later than 21 days before the Wrestler's participation at an International Event. 4.4.3.2 Wrestlers participating in International Events who are not included in the FILA Registered Testing Pool must, except in emergency situations, request a TUE from FILA no later than 21 days before the Wrestler's participation at an International Event. 4.4.4 WADA, at the request of a Wrestler or on its own initiation, may review the granting or denial of any TUE to an International Level Wrestler or a national level Wrestler that is included in a Registered Testing Pool. If WADA determines that the granting or denial of a TUE did not comply with the International Standard for Therapeutic Use Exemptions in force at the time then WADA may reverse that decision. Decisions on TUE's are subject to further appeal as provided in Article 13. FILA Anti-Doping Regulations Update January 2009 11

ARTICLE 5 TESTING 5.1 Testing Authority empowered to test All Wrestlers affiliated with a National Federation shall be subject to In-Competition Testing by FILA, the Wrestler's National Federation, and any other Anti-Doping Organization responsible for Testing at a Competition or Event in which they participate. All Wrestlers affiliated with a National Federation shall also be subject to Out-of-Competition Testing at any time or any place, by FILA, by WADA, by the Wrestler's National Federation, by the National Anti-Doping Organization of any country where the Wrestler is present and by the IOC during the Olympic Games. The Anti-Doping Organization of any country where the Wrestler is staying, will have first to inform the Wrestler that he/she is required to undergo a sample collection, produce identification and authorization to sample collection, to provide the services of an interpreter, if needed, and to inform the athlete of his/her right to have one or several representatives who could act as witnesses. 5.1.1 Periodicity of out-of-competition testing Out-of-competition testing must be carried out outside the competition period established by FILA through the dates of its official calendar to which must be added the two days preceding the start of the competition which are used for checking and controlling and are considered as an integrate part of the competition period. During this whole period, the Wrestlers are considered to be competing and are under the sole responsibility of FILA. 5.1.2 Responsibility for FILA Testing 5.2 Testing Standards The FILA [Medical and Anti-Doping Department] shall be responsible for overseeing all Testing conducted by FILA. Testing may be conducted by members of the FILA [Medical and Anti- Doping Department] or by other qualified persons or qualified body, so authorized by FILA. Testing conducted by FILA, its National Federations or authorized Anti- Doping Organizations, shall be in substantial conformity with the International Standard for Testing in force at the time of testing. 5.2.1 Blood (or other non-urine) samples may be used either to detect Prohibited Substances or Prohibited Methods or for screening procedure purposes only. If the blood is collected for screening only, it will have no other consequences for the Wrestler other than to identify him/her for a urine test under these anti-doping rules. In these circumstances, the FILA may decide at its own FILA Anti-Doping Regulations Update January 2009 12

discretion which blood parameters are to be measured in the screening sample and what levels of those parameters will be used to indicate that an wrestler should be selected for a urine test. 5.3 Coordination of Testing FILA, its National Federations, the National Anti-Doping Organizations shall promptly report completed tests through the WADA clearinghouse to avoid unnecessary duplication in testing. 5.4 Wrestler Whereabouts Requirements 5.4.1 FILA shall identify a Registered Testing Pool of those Wrestlers who are subject to doping tests and are required to provide up-todate whereabouts information to WADA and FILA. The Registered Testing Pool will be formed of the medal-winners at the World and Continental Championships. FILA may revise its Registered Testing Pool from time to time as appropriate. Each Wrestler in the Registered Testing Pool shall file quarterly reports with FILA and WADA on forms provided by FILA which specify on a daily basis the locations and times where the Wrestler will be residing, training and competing. Wrestlers shall update this information as necessary so that it is current at all times. The ultimate responsibility for providing whereabouts information rests with each Wrestler; however, it shall be the responsibility of each National Federation to use its best efforts to assist FILA in obtaining whereabouts information as requested by FILA. 5.4.2 Any Wrestler in the FILA Registered Testing Pool who is unavailable for Testing on three attempts during any period of 18 consecutive months shall be considered to have committed an anti-doping rule violation pursuant to Article 2.4. For each attempt, the Doping Control Officer shall visit all locations during the times specified by the Wrestler for that date and shall stay two hours at each location. Notification shall be sent to the Wrestler between each attempt which is to be counted as an unavailable test. 5.4.3 Any Wrestler in the FILA Registered Testing Pool who fails to timely submit a required quarterly whereabouts report after receipt of two formal written warnings from FILA or a National Federation to do so in the preceding 18 months shall be considered to have committed an anti-doping rule violation pursuant to Article 2.4. 5.4.4 Each National Federation shall also assist the National Anti-Doping Organization in establishing a national level Registered Testing Pool of top level national Wrestlers who are not already included in FILA's Registered Testing Pool. The National Federation / FILA Anti-Doping Regulations Update January 2009 13

National Anti-Doping Organization may establish its own whereabouts reporting requirements and criteria for Article 2.4 violations applicable to those Wrestlers. 5.4.5 Whereabouts information provided pursuant to Articles 5.4.1 and 5.4.4 shall be shared with WADA and other Anti-Doping Organizations having jurisdiction to test a Wrestler on the strict condition that it be used only for Doping Control purposes. 5.5 Retirement and Return to Competition 5.5.1 A Wrestler who has been identified by FILA for inclusion in FILA s Registered Testing Pool shall continue to be subject to these Anti-Doping Rules, including the obligation to be available for No Advance Notice Out-of-Competition Testing, unless and until the Wrestler gives written notice to FILA that he or she has retired or until he or she no longer satisfies the criteria for inclusion in the FILA's Registered Testing Pool and has been so informed by FILA. 5.5.2 A Wrestler who has given notice of retirement to FILA may not resume competing unless he or she notifies FILA at least six months before he or she expects to return to competition and is available for unannounced Out-of-Competition Testing, at any time during the period before actual return to competition. 5.5.3 National Federations/National Anti-Doping Organizations may establish similar requirements for retirement and returning to competition for Wrestlers in the national Registered Testing Pool. 5.6 Selection of Wrestlers to be tested 5.6.1 At International Events, the FILA shall determine the number of finishing placement tests, random tests and target tests to be performed. 5.6.1.1 On the occasion of senior, junior World Championships, senior, junior Continental Championships, Continental Cups and World Cups all the medalled Wrestlers shall be tested. If need be, taking into account the moderate number of participating Wrestlers, the number of Wrestlers to be tested shall be reduced, further to the FILA s decision. In case there is a disqualification for doping, the bronze-medal holder who lost in his line of elimination will rise in the classification. The bronze medal will be also awarded to the loser of the finals 3 / 4 of the same line. FILA Anti-Doping Regulations Update January 2009 14

5.6.2 At National Events, each National Federation shall determine the number of Wrestlers selected for testing in each competition and the procedures for selecting the Wrestlers for testing. 5.6.3 In addition to the selection procedures set forth in Article 5.6.1 the Anti-Doping Commission at International Events, and the National Federation at National Events, may also select wrestlers or teams for Target Testing so long as such Target Testing is not used for any purpose other than legitimate Doping Control purposes. 5.6.4 Wrestlers shall be selected for Out-of-Competition Testing by the FILA Anti-Doping Department and by National Federations through a process that substantially complies with the International Standard for Testing in force at the time of selection. 5.6.5 If the event is a qualifying competition for the Olympic Games, each qualified Wrestler (male or female) must obligatorily undergo a doping test. 5.7 National Federations and the organizing committees for National Federation Events shall provide access to Independent Observers at Events as directed by FILA. ARTICLE 6 ANALYSIS OF SAMPLES Doping Control Samples collected under these Anti-Doping Rules shall be analyzed in accordance with the following principles: 6.1 Use of Approved Laboratories The Doping Control Samples will be sent for analysis only to WADAaccredited laboratories or as otherwise approved by WADA. The choice of the WADA-accredited laboratory (or other laboratory or method approved by WADA) used for the Sample analysis shall be determined exclusively by the Anti-Doping Organization responsible for results management. 6.2 Purpose of Collection and Analysis of Samples Samples shall be analyzed to detect Prohibited Substances and Prohibited Methods identified on the Prohibited List and other substances as may be directed by WADA pursuant to the Monitoring Program described in Article 4.5 of the Code or to assist the FILA in profiling relevant parameters in a Wrestler s urine, blood or other matrix, including DNA or genomic profiling, for anti-doping purposes. FILA Anti-Doping Regulations Update January 2009 15

6.3 Research on samples No Sample may be used for any purpose other than as described in Article 6.2, without the Wrestler's written consent. Samples used for purposes other than Article 6.2 shall have any means of identification removed such that they cannot be traced back to a particular Wrestler. 6.4 Standards for Sample analysis and reporting Laboratories shall analyze Doping Control Samples and report results in conformity with the International Standard for Laboratories. 6.5 Retesting Samples A sample may be reanalyzed for the purpose of Article 6.2 at any time exclusively at the direction of the Anti-Doping Organization that collected the sample or WADA. The circumstances and conditions for retesting samples shall conform to the requirements of the International Standard for Laboratories. ARTICLE 7 RESULTS MANAGEMENT 7.1 Results Management for tests initiated by FILA Results management for tests initiated by FILA (including tests performed by WADA pursuant to agreement with FILA) shall proceed as set forth below: 7.1.1 The results from all analyses must be sent to FILA in encoded form, in a report signed by an authorized representative of the laboratory. All communication must be conducted in such a way that the results of the analyses are confidential. 7.1.2 Upon receipt of an A Sample Adverse Analytical Finding, the FILA Anti-Doping Administrator shall conduct a review, upon receipt of the identifying sheet of the sampling report, provided that this document was duly sent to FILA, to determine whether: (a) an applicable therapeutic use exemption has been granted or will be granted as provided in the International Standard for Therapeutic Use Exemptions, or (b) there is any apparent departure from the International Standards for Testing or International Standard for Laboratories caused the Adverse Analytical Finding. 7.1.3 If the initial review under Article 7.1.2 does not reveal an applicable therapeutic use exemption or departure from the International Standard for Testing or the International Standard for Laboratories analysis in force at the time of Testing or analysis that undermines the validity of the Adverse Analytical Finding, FILA shall promptly notify the Wrestler of: (a) the Adverse Analytical Finding; (b) the anti-doping Regulations violated; (c) the Wrestler's right to promptly FILA Anti-Doping Regulations Update January 2009 16

request the analysis of the B Sample or, failing such request, that the B Sample analysis may be deemed waived; (d) the scheduled date, time and place for the B Sample analysis if the Athlete or Anti-Doping Organization chooses to request an analysis of the B Sample; (e) the right of the Wrestler and/or the Wrestler's representative to attend the B Sample opening and analysis within the time period specified in the International Standard for Laboratories if such analysis is requested; and (f) the Wrestler's right to request copies of the A and B Sample laboratory documentation package which includes information as required by the International Standard for Laboratory Analysis. FILA shall also notify the Wrestler s National Anti-Doping Organization and WADA. If FILA decides not to bring forward the Adverse Analytical Finding as an antidoping violation, it shall so notify the Wrestler, the Wrestler s National Anti-Doping Organization and WADA. 7.1.4 Arrangements shall be made for Testing the B Sample within three weeks of the notification described in Article 7.1.3. A Wrestler may accept the A Sample analytical results by waiving the requirement for B Sample analysis. FILA may nonetheless elect to proceed with the B Sample analysis. 7.1.5 The Wrestler and/or his representative shall be allowed to be present at the analysis of the B Sample within the time period specified in the International Standard for Laboratories. Also a representative of the Wrestler's National Federation as well as a representative of FILA shall be allowed to be present. 7.1.6 If the B Sample proves negative, the entire test shall be considered negative and the Wrestler, his National Federation, and the FILA shall be so informed. 7.1.7 If a Prohibited Substance or the Use of a Prohibited Method is identified, the findings shall be reported to the Wrestler, his National Federation, FILA, and to WADA. 7.1.8 The FILA Anti-Doping Administrator shall conduct any followup investigation as may be required by the Prohibited List. Upon completion of such follow-up investigation, FILA shall promptly notify the Wrestler regarding the results of the follow-up investigation and whether or not FILA asserts that an anti-doping rule was violated. 7.1.9 For apparent anti-doping rule violations that do not involve Adverse Analytical Findings, FILA shall conduct any necessary follow-up investigation and shall then promptly notify the Wrestler of the anti-doping rule which appears to have been violated, and the basis of the violation. FILA Anti-Doping Regulations Update January 2009 17

7.2 Results Management for Tests Initiated During Other International Events Results management and the conduct of hearings from a test by the International Olympic Committee or a major Wrestling Event Organization shall be managed, as far as sanctions beyond disqualification from the event or the results of the event, by FILA. 7.3 Results Management for Tests initiated by National Federations Results management conducted by National Federations shall be consistent with the general principles for effective and fair results management which underlie the detailed provisions set forth in Article 7.1. Results of all Doping Controls shall be reported to FILA within 14 days of the conclusion of the National Federation's results management process. Any apparent anti-doping rule violation by a Wrestler who is a member of that National Federation shall be promptly referred to an appropriate hearing panel established pursuant to the rules of the National Federation or national law. Apparent anti-doping rule violations by Wrestlers who are members of another National Federation shall be referred to the Wrestler's National Federation for hearing. 7.4 Principles Applicable to Provisional Suspensions Signatories shall adopt rules, applicable to any Event for which the Signatory is the ruling body or for any team selection process for which the Signatory is responsible or where the Signatory is the applicable International Federation or has results management authority over the alleged anti-doping rule violation, providing that when an A Sample Adverse Analytical Finding is received for a Prohibited Substance, other than a Specified Substance, a Provisional Suspension shall be imposed promptly after the review and notification described in articles 7.1 and 7.2. Provided, however, that a Provisional Suspension may not be imposed unless the Wrestler is given either: (a) an opportunity for a Provisional Hearing either before imposition of the Provisional Suspension or on a timely basis after imposition of the Provisional Suspension; or (b) an opportunity for an expedited hearing in accordance with Article 8 (Right to a Fair Hearing) on a timely basis after imposition of a Provisional Suspension. ARTICLE 8 RIGHT TO A FAIR HEARING 8.1 Fair Hearings Hearings arising out of FILA s testing or tests at International Events. 8.1.1 The FILA shall appoint for each case a Committee consisting of a Chairman and four other experts with experience in anti- FILA Anti-Doping Regulations Update January 2009 18

doping ("FILA Doping Hearing Committee"). The Chair shall be a lawyer. Each Committee member shall be otherwise independent of the FILA Bureau. Each Committee member shall be appointed for each case individually. 8.1.2 When it appears, following the Results Management process described in Article 7, that these Anti-Doping Regulations have been violated in connection with FILA Testing or Testing at an International Event then the case shall be assigned to the FILA Doping Hearing Committee for adjudication. 8.1.3 The Chair of the FILA Doping Hearing Committee shall appoint three members from the Committee (which may include the Chair) to hear each case. At least one appointed member shall be a lawyer. The appointed members shall have had no prior involvement with the case and shall not have the same nationality as the Wrestler or other person alleged to have violated these Anti-Doping Regulations. 8.1.4 Hearings pursuant to this article shall be completed expeditiously following the completion of the results management process described in Article 7. Hearings held in connection with Events may be conducted on an expedited basis. 8.1.5 The National Federation of the Wrestler or other Person alleged to have violated these Anti-Doping Regulations may attend the hearing as an observer. 8.1.6 FILA shall keep WADA fully apprised as to the status of pending cases and the result of all hearings. 8.1.7 A Wrestler or other Person may forego a hearing by writing to FILA within 14 days after the notification of the laboratory analysis, giving all useful explanations for his defense. He could also forego a hearing or to provide explanations by acknowledging the Anti-Doping Rule violation and accepting consequences consistent with Articles 9 and 10 as proposed by FILA. When no hearing occurs, FILA shall submit to the persons described in Article 13.2.3 a reasoned decision explaining the action taken. 8.1.8 Pursuant Article 13, the decisions of the FILA Doping Hearing Committee may be appealed to the FILA Federal Appeal Commission and ultimately to the Court of Arbitration for Sport (CAS). 8.2 Hearings Arising Out of National Testing 8.2.1 When it appears, following the Results Management process described in Article 7, that these Anti-Doping Regulations have been violated in connection with Testing other than in connection with FILA Testing or Testing at an International Event, the Wrestler or other Person involved shall be brought before a disciplinary panel of the Wrestler or other Person's FILA Anti-Doping Regulations Update January 2009 19

National Federation for a hearing to adjudicate whether a violation of these Anti-Doping Regulations occurred and if so what consequences should be imposed. 8.2.2 Hearings pursuant to this Article 8.2 shall be completed expeditiously and in all cases within three months of the completion of the Results Management process described in Article 7. Hearings held in connection with Events may be conducted by an expedited process. If the completion of the hearing is delayed beyond three months, FILA may elect to bring the case directly before the FILA Doping Hearing Committee at the responsibility and at the expense of the National Federation. 8.2.3 National Federations shall keep FILA and WADA fully apprised as to the status of pending cases and the results of all hearings. 8.2.4 FILA and WADA shall have the right to attend hearings as an observer. 8.2.5 The Wrestler or other Person may forego a hearing by acknowledging the violation of these Anti-Doping Regulations and accepting Consequences consistent with Articles 9 and 10 as proposed by the National Federation. Where no hearing occurs, the National Federation shall submit to the persons described in Article 13.2.3 a reasoned decision explaining the action taken. 8.2.6 Decisions by National Federations, whether as the result of a hearing or the Wrestler or other Person's acceptance of Consequences, may be appealed as provided in Article 13. 8.2.7 Hearing decisions by the National Federation shall not be subject to further administrative review at the national level except as provided in Article 13 or required by applicable national law. 8.3 Principles for a Fair Hearing All hearings pursuant to either Article 8.1 or 8.2 shall respect the following principles: - a timely hearing; - fair and impartial hearing body; - the right to be represented by counsel at the Person's own expense; - the right to be fairly and timely informed of the asserted antidoping rule violation; - the right to respond to the asserted anti-doping rule violation and resulting Consequences; FILA Anti-Doping Regulations Update January 2009 20

- the right of each party to present evidence, including the right to call and question witnesses (subject to the hearing body's discretion to accept testimony by telephone or written submission); - the Person's right to an interpreter at the hearing, with the Doping Committee to determine the identity, and responsibility for the cost of the interpreter; and - a timely, written, reasoned decision, specifically including an explanation of the reasons(s) for any period of Ineligibility. ARTICLE 9 AUTOMATIC DISQUALIFICATION OF INDIVIDUAL RESULTS A violation of these Anti-Doping Regulations in Individual Sports in connection with an In-Competition test automatically leads to Disqualification of the individual result obtained in that Competition with all resulting consequences, including forfeiture of any medals, points and prizes. ARTICLE 10 SANCTIONS ON INDIVIDUALS 10.1 Disqualification of Results in Event during which an Anti-Doping Rule Violation Occurs An Anti-Doping Rule violation occurring during or in connection with an Event may lead to Disqualification of all of the Wrestler's individual results obtained in that Event with all consequences, including forfeiture of all medals, points and prizes, except as provided in Article 10.1.1. 10.1.1 If the Wrestler establishes that he or she bears no fault or negligence for the violation, the wrestler's individual results in other Competitions shall not be disqualified, unless the Wrestler's results in competitions other than the competition, in which the anti-doping rule violation occurred, were not likely to have been affected by the Wrestler's anti-doping rule violation. 10.2 Imposition of Ineligibility for Prohibited Substances and Prohibited Methods The period of Ineligibility imposed for a violation of Article 2.1 (Presence of Prohibited Substance or its Metabolites or Markers), Article 2.2 (Use or Attempted Use of Prohibited Substance or Prohibited Method), and Article 2.6 (Possession of Prohibited Substances and Methods) shall be as follows, unless the conditions for eliminating or reducing the period of Ineligibility, as provided in Article 10.4 and 10.5, or the conditions for increasing the period of Ineligibility, as provided in Article 10.6, are met: FILA Anti-Doping Regulations Update January 2009 21

First violation: two (2) years' ineligibility 10.3 Ineligibility for Other Anti-Doping Rule Violations The period of Ineligibility for anti-doping rule violations other than as provided in Article 10.2 shall be as follows: 10.3.1 For violations of Article 2.3 (refusing or failing to submit to Sample collection) or Article 2.5 (Tampering with Doping Control), the Ineligibility period shall be two (2) years unless the conditions provided in Article 10.5, or the conditions provided in Article 10.6, are met. 10.3.2 For violations of Articles 2.7 (Trafficking) or 2.8 (Administration of Prohibited Substance or Prohibited Method), the period of Ineligibility imposed shall be a minimum of four (4) years up to lifetime Ineligibility unless the conditions provided in Article 10.5 are met. An anti-doping rule violation involving a Minor shall be considered a particularly serious violation, and, if committed by Wrestler Support Personnel for violations other than Specified Substances referenced in Article 4.2.2, shall result in lifetime Ineligibility for such Wrestler Support Personnel. In addition, significant violations of such Articles which also violate non-sporting laws and regulations shall be reported to the competent administrative, professional or judicial authorities. 10.3.3 For violations of Article 2.4 (whereabouts filing failures and/or missed tests), the period of Ineligibility shall be at a minimum one (1) year and at a maximum two (2) years based on the Wrestler s degree of fault. 10.4 Elimination or Reduction of the Period of Ineligibility for specified substances under specific circumstances Where an Athlete or other Person can establish how a Specified Substance entered his or her body or came into his or her possession and that such Specified Substance was not intended to enhance the Athlete s sport performance or mask the use of a performanceenhancing substance, the period of Ineligibility found in Article 10.2 shall be replaced with the following: First violation: At a minimum, a reprimand and no period of Ineligibility from future Events, and at a maximum, two (2) years Ineligibility. To justify any elimination or reduction, the Athlete or other Person must produce corroborating evidence in addition to his or her word which establishes to the comfortable satisfaction of the hearing panel the absence of intent to enhance sport performance or mask the use of a performance enhancing substance. The Athlete or other Person s FILA Anti-Doping Regulations Update January 2009 22

degree of fault shall be the criteria considered in assessing any reduction of the period of Ineligibility. 10.5 Elimination or Reduction of the period of Ineligibility Based on Exceptional Circumstances 10.5.1 If a Wrestler establishes in an individual case that he or she bears No Fault or Negligence, the otherwise applicable period of Ineligibility shall be eliminated. When a Prohibited Substance or its Markers or Metabolites is detected in a Wrestler's Sample in violation of Article 2.1 (presence of Prohibited Substance), the Wrestler must also establish how the Prohibited Substance entered his or her system in order to have the period of Ineligibility eliminated. In the event this Article is applied and the period of Ineligibility otherwise applicable is eliminated, the anti-doping rule violation shall not be considered a violation for the limited purpose of determining the period of Ineligibility for multiple violations under Article 10.7. 10.5.2 If a Wrestler or other person establishes in an individual case that he or she bears No Significant Fault or Negligence, then the period of Ineligibility may be reduced, but the reduced period of Ineligibility may not be less than one-half of the period of Ineligibility otherwise applicable. If the otherwise applicable period of Ineligibility is a lifetime, the reduced period under this section may be no less than 8 years. When a Prohibited Substance or its Markers or Metabolites is detected in a Wrestler's Sample in violation of Article 2.1 (presence of Prohibited Substance or method), the Wrestler must also establish how the Prohibited Substance entered his or her system in order to have the period of Ineligibility reduced. 10.5.3 The FILA Anti-Doping Committee may, prior to a final appellate decision under Article 13 or the expiration of the time to appeal, suspend a part of the period of Ineligibility imposed in an individual case where the Wrestler or other person has provided Substantial Assistance to FILA which results in FILA discovering or establishing an anti-doping rule violation by another Person or which results in a criminal or disciplinary body discovering or establishing a criminal offence or the breach of professional rules by another person. After a final appellate decision under Article 13 or the expiration of time to appeal, FILA may only suspend a part of the applicable period of Ineligibility with the approval of WADA. The extent to which the otherwise applicable period of Ineligibility may be suspended shall be based on the seriousness of the antidoping rule violation committed by the Wrestler or other person and the significance of the Substantial Assistance provided by the Wrestler or other person to the effort to FILA Anti-Doping Regulations Update January 2009 23